Trial Profile
Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients (SHIVERING 2)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Feb 2019
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Acronyms SHIVERING 2
- 28 Jan 2019 Status changed from active, no longer recruiting to completed.
- 07 Sep 2016 Planned End Date changed from 1 Jun 2016 to 1 Dec 2016.
- 07 Sep 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2016.